Strain identifier
BacDive ID: 7668
Type strain:
Species: Micrococcus luteus
Strain Designation: 130.21
Strain history: CIP <- 1953, Y.A. Chabbert, Inst. Pasteur, Paris, France <- ATCC, Micrococcus flavus <- FDA, USA: strain PCI 1001, Sarcina lutea <- E.R. Squibb & Sons
NCBI tax ID(s): 1270 (species)
General
@ref: 656
BacDive-ID: 7668
DSM-Number: 1790
keywords: Bacteria, obligate aerobe, mesophilic, Gram-positive, oval-shaped
description: Micrococcus luteus 130.21 is an obligate aerobe, mesophilic, Gram-positive bacterium that was isolated from Assay of bacitracin in body fluids.
NCBI tax id
- NCBI tax id: 1270
- Matching level: species
strain history
@ref | history |
---|---|
656 | <- ATCC <- Commercial Solvent Corp., 130.21 (Micrococcus flavus) |
120705 | CIP <- 1953, Y.A. Chabbert, Inst. Pasteur, Paris, France <- ATCC, Micrococcus flavus <- FDA, USA: strain PCI 1001, Sarcina lutea <- E.R. Squibb & Sons |
doi: 10.13145/bacdive7668.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/actinomycetota
- domain: Bacteria
- phylum: Actinomycetota
- class: Actinomycetes
- order: Micrococcales
- family: Micrococcaceae
- genus: Micrococcus
- species: Micrococcus luteus
- full scientific name: Micrococcus luteus (Schroeter 1872) Cohn 1872 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Bacteridium luteum
@ref: 656
domain: Bacteria
phylum: Actinobacteria
class: Actinobacteria
order: Actinomycetales
family: Micrococcaceae
genus: Micrococcus
species: Micrococcus luteus
full scientific name: Micrococcus luteus (Schroeter 1872) Cohn 1872 emend. Nouioui et al. 2018
strain designation: 130.21
type strain: no
Morphology
cell morphology
- @ref: 120705
- gram stain: positive
- cell shape: oval-shaped
- motility: no
colony morphology
- @ref: 120705
- hemolysis ability: 1
Culture and growth conditions
culture medium
@ref | name | growth | link | composition |
---|---|---|---|---|
656 | NUTRIENT AGAR (DSMZ Medium 1) | yes | https://mediadive.dsmz.de/medium/1 | Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water |
41170 | MEDIUM 3 - Columbia agar | yes | Columbia agar (39.000 g);distilled water (1000.000 ml) | |
120705 | CIP Medium 3 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=3 | |
120705 | CIP Medium 72 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72 |
culture temp
@ref | growth | type | temperature | range |
---|---|---|---|---|
656 | positive | growth | 30 | mesophilic |
41170 | positive | growth | 30 | mesophilic |
47536 | positive | growth | 30 | mesophilic |
120705 | positive | growth | 22-41 | |
120705 | no | growth | 10 | psychrophilic |
120705 | no | growth | 45 | thermophilic |
Physiology and metabolism
oxygen tolerance
- @ref: 120705
- oxygen tolerance: obligate aerobe
antibiogram
@ref | medium | incubation temperature | incubation time | oxygen condition | Penicillin G | oxacillin | ampicillin | ticarcillin | mezlocillin | cefalotin | cefazolin | cefotaxime | aztreonam | imipenem | tetracycline | chloramphenicol | gentamycin | amikacin | vancomycin | erythromycin | lincomycin | ofloxacin | norfloxacin | colistin | pipemidic acid | nitrofurantoin | bacitracin | polymyxin b | kanamycin | neomycin | doxycycline | ceftriaxone | clindamycin | fosfomycin | moxifloxacin | linezolid | nystatin | quinupristin/dalfopristin | teicoplanin | piperacillin/tazobactam |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
656 | Mueller-Hinton Agar | 30 | 2 | aerob | >50 | 30 | >50 | >50 | 42-44 | >50 | >50 | 50 | 0 | >50 | >50 | >50 | 40 | 40 | 32 | 50 | 48-50 | 26-28 | 16-18 | 10 | 0 | 8 | 48 | 20 | 34 | 32 | 50 | >50 | >50 | 18 | 38-40 | >50 | 0 | 48 | 30 | 40 |
656 | Mueller-Hinton Agar | 30 | aerob | 42 | 24-26 | 42 | 44-46 | 36-38 | 44 | 42-44 | 40 | 0 | >50 | 42 | 40 | 32-34 | 34-36 | 28 | 36-38 | 36 | 24-26 | 22 | 14 | 14 | 8-10 | 40 | 20 | 30-32 | 30 | 42 | 40 | 42-44 | 18 | 32 | 42-44 | 0 | 42 | 28-30 | 34-36 | |
656 | Mueller-Hinton Agar | 42-44 | 28 | 42 | 50 | 40 | 42-44 | 46-48 | 42 | 0 | >50 | 40-42 | 44-46 | 30 | 34-36 | 30 | 40-42 | 38 | 26-28 | 22-24 | 16 | 14 | 10 | 40 | 18 | 30 | 28-30 | 40 | 40 | 40-42 | 22-24 | 32-34 | 40-42 | 0 | 42-44 | 30 | 40 | |||
656 | Mueller-Hinton Agar | 30 | 2 | aerob | >50 | 28-30 | 50 | >50 | >50 | >50 | >50 | 50 | 0 | >50 | 46 | 50 | 38-40 | 44 | 30 | 50 | 50 | 28 | 20 | 12 | 8 | 0 | 46-48 | 18 | 36-38 | 34 | 44 | 50 | >50 | 12 | 40 | >50 | 0 | 46-48 | 28-30 | 40 |
656 | Mueller-Hinton Agar | 37 | 40 | 24 | 40 | 44 | 36 | 40 | 42 | 38-40 | 0 | 50 | 38-40 | 38 | 30 | 32 | 26-28 | 32 | 32 | 22 | 16 | 14 | 0 | 6-8 | 38 | 18 | 26 | 26 | 36 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | ||
656 | Mueller Hinton | 30 | aerob | 50 | 28 | 48 | >50 | 42-44 | 50 | >50 | 50 | 0 | >50 | 44 | 48 | 38 | 40-42 | 28 | 46-48 | 42-44 | 26 | 16-18 | 12 | 0 | 0 | 42 | 20 | 34-36 | 32 | 42-44 | 48 | 50 | 16-18 | 38 | 50 | 0 | 44-46 | 28 | 40-42 | |
656 | Mueller Hinton | 30 | aerob | >50 | 26 | 50 | >50 | 42 | >50 | 50 | 48-50 | 0 | >50 | 42 | 46 | 40 | 40-42 | 30 | 50 | 48-50 | 26 | 16 | 10 | 0 | 0 | 46 | 20 | 34 | 34 | 44 | 50 | 50 | 10 | 40 | 50 | 0 | 46 | 30 | 42 |
murein
- @ref: 656
- murein short key: A11. pep
- type: A2 L-Lys peptide subunit
metabolite utilization
@ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
---|---|---|---|---|
120705 | 606565 | hippurate | + | hydrolysis |
120705 | 17632 | nitrate | - | reduction |
120705 | 16301 | nitrite | - | reduction |
metabolite production
- @ref: 120705
- Chebi-ID: 35581
- metabolite: indole
- production: no
metabolite tests
- @ref: 120705
- Chebi-ID: 15688
- metabolite: acetoin
- voges-proskauer-test: +
enzymes
@ref | value | activity | ec |
---|---|---|---|
68382 | alpha-fucosidase | - | 3.2.1.51 |
68382 | alpha-mannosidase | - | 3.2.1.24 |
68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
68382 | beta-glucosidase | - | 3.2.1.21 |
68382 | alpha-glucosidase | + | 3.2.1.20 |
68382 | beta-glucuronidase | - | 3.2.1.31 |
68382 | beta-galactosidase | - | 3.2.1.23 |
68382 | alpha-galactosidase | - | 3.2.1.22 |
68382 | naphthol-AS-BI-phosphohydrolase | + | |
68382 | acid phosphatase | + | 3.1.3.2 |
68382 | alpha-chymotrypsin | - | 3.4.21.1 |
68382 | trypsin | - | 3.4.21.4 |
68382 | cystine arylamidase | - | 3.4.11.3 |
68382 | valine arylamidase | - | |
68382 | leucine arylamidase | + | 3.4.11.1 |
68382 | lipase (C 14) | + | |
68382 | esterase lipase (C 8) | + | |
68382 | esterase (C 4) | + | |
68382 | alkaline phosphatase | + | 3.1.3.1 |
120705 | oxidase | - | |
120705 | beta-galactosidase | + | 3.2.1.23 |
120705 | alcohol dehydrogenase | - | 1.1.1.1 |
120705 | gelatinase | +/- | |
120705 | amylase | - | |
120705 | DNase | - | |
120705 | caseinase | - | 3.4.21.50 |
120705 | catalase | + | 1.11.1.6 |
120705 | coagulase | - | |
120705 | tween esterase | - | |
120705 | gamma-glutamyltransferase | - | 2.3.2.2 |
120705 | lecithinase | - | |
120705 | lipase | - | |
120705 | lysine decarboxylase | - | 4.1.1.18 |
120705 | ornithine decarboxylase | - | 4.1.1.17 |
120705 | phenylalanine ammonia-lyase | - | 4.3.1.24 |
120705 | urease | + | 3.5.1.5 |
fatty acid profile
fatty acids
@ref fatty acid percentage ECL 47536 C14:0 0.5 14 47536 C15:0 0.3 15 47536 C16:0 1 16 47536 C11:0 ANTEISO 0.4 10.693 47536 C13:0 ANTEISO 1.9 12.701 47536 C13:0 iso 0.4 12.612 47536 C14:0 ISO 4.2 13.618 47536 C15:0 ANTEISO 75.2 14.711 47536 C15:0 ISO 12.7 14.621 47536 C16:0 iso 1.8 15.626 47536 C17:0 anteiso 1.1 16.722 47536 C18:2 ω6,9c/C18:0 ANTE 0.7 17.724 - type of FA analysis: whole cell analysis
- method/protocol: CCUG
API zym
@ref | Control | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120705 | - | + | + | + | + | + | - | - | - | - | + | + | - | - | - | + | - | - | - | - |
API biotype100
@ref | GLU | FRU | GAL | TRE | MNE | SBE | MEL | SAC | RAF | MTE | MAL | LAC | LTE | MbGa | MaGa | CEL | GEN | MbGu | ESC | RIB | ARA | XYL | PLE | RHA | FUC | MLZ | DARL | LARL | XLT | DUL | TAG | GLY | INO | MAN | MTL | TUR | SOR | ADO | HBG | LYX | ERY | MDG | 3MDG | SAT | MUC | LTAT | DTAT | MTAT | DMLT | LMLT | CATE | TATE | TTE | CIT | GRT | GAT | 2KG | 5KG | TRY | NAG | GNT | PAC | PAT | pOBE | QAT | GTE | mOBE | BAT | PPAT | CMT | TGE | BET | PCE | ABT | HIN | LAT | CAP | CYT | HIS | SUC | FUM | GRE | GYT | AVT | ETN | TTN | GLN | ITA | 3OBU | APT | GTT | PRO | DALA | LALA | SER | MNT | PROP | TYR | 2KT |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120705 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Isolation, sampling and environmental information
isolation
- @ref: 47536
- sample type: Assay of bacitracin in body fluids
isolation source categories
- Cat1: #Host Body Product
- Cat2: #Fluids
Safety information
risk assessment
@ref | biosafety level | biosafety level comment |
---|---|---|
656 | 1 | Risk group (German classification) |
120705 | 1 | Risk group (French classification) |
Sequence information
GC content
- @ref: 656
- GC-content: 65.0
External links
@ref: 656
culture collection no.: DSM 1790, ATCC 10240, CCM 732, DSM 20490, IFO 3242, NBRC 3242, NCIB 8166, NCTC 7743, CCUG 21988, FDA 16, CIP 53.160, IMET 10759, NCDO 982, NCIMB 8166
straininfo link
- @ref: 77111
- straininfo: 13723
literature
Pubmed-ID | title | authors | journal | DOI | year | mesh | topic | topic2 |
---|---|---|---|---|---|---|---|---|
12396393 | Accelerated solvent extraction of animal feedingstuffs for microbial growth inhibition screening for the presence of antimicrobial feed additives. | Higgins HC, McEvoy JD | Food Addit Contam | 10.1080/02652030210145063 | 2002 | Animal Feed/*analysis, Animals, Anti-Bacterial Agents/analysis, Bacitracin/analysis, Drug Residues/*analysis, Drug Resistance, Microbial, False Negative Reactions, False Positive Reactions, Food Additives/*analysis, Glycopeptides, Sensitivity and Specificity, Solvents/chemistry, Spiramycin/analysis, Tylosin/analysis, Virginiamycin/analysis | ||
16305671 | Antimicrobial activity of a nisin-activated plastic film for food packaging. | Mauriello G, De Luca E, La Storia A, Villani F, Ercolini D | Lett Appl Microbiol | 10.1111/j.1472-765X.2005.01796.x | 2005 | Animals, Anti-Bacterial Agents/*pharmacology, Food Microbiology, Food Packaging/*methods, Food Preservation/*methods, Micrococcus luteus/*drug effects/growth & development, Milk/microbiology, Nisin/*pharmacology | Biotechnology | Pathogenicity |
17042189 | Development and in-house validation of a microbiological assay for determination of cefepime in injectable preparations. | Souza MJ, Kulmann RR, Silva LM, Nogueira DR, Zimmermann ES, Schmidt CA | J AOAC Int | 2006 | Analysis of Variance, Anti-Bacterial Agents/administration & dosage/analysis/pharmacology/standards, Biological Assay/*methods/standards/statistics & numerical data, Cefepime, Cephalosporins/administration & dosage/*analysis/pharmacology/standards, Chromatography, Liquid, Injections, Mass Spectrometry, Micrococcus luteus/drug effects, Powders, Reference Standards, Reproducibility of Results | Pathogenicity | ||
17657855 | A rapid and accurate 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay for quantification of bacteriocins with nisin as an example. | Wang F, Cao LT, Hu SH | J Zhejiang Univ Sci B | 10.1631/jzus.2007.B0549 | 2007 | Bacteriocins/*analysis/metabolism, Colorimetry/*methods, Immunodiffusion, Micrococcus luteus/metabolism, *Nisin, Regression Analysis, Tetrazolium Salts/*analysis, Thiazoles/*analysis, Time Factors | Metabolism | |
18193752 | Development of a microbiological assay to determine the potency of ceftiofur sodium powder. | Souza MJ, Rolim CM, Melo J, Souza Filho PS, Bergold AM | J AOAC Int | 2007 | Anti-Bacterial Agents/*analysis, Biological Assay, Cephalosporins/*analysis, Chromatography, Liquid, Indicators and Reagents, Micrococcus luteus/drug effects, Powders, Reproducibility of Results, Solutions | Pathogenicity | ||
21859126 | N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry. | Wencewicz TA, Yang B, Rudloff JR, Oliver AG, Miller MJ | J Med Chem | 10.1021/jm200794r | 2011 | Alkenes/chemical synthesis/chemistry, Anti-Bacterial Agents/*chemical synthesis/chemistry/pharmacology, Colony Count, Microbial, Crystallography, X-Ray, Drug Resistance, Bacterial, Gram-Positive Bacteria/drug effects, Hydroxylamines/*chemical synthesis/chemistry/pharmacology, Microbial Sensitivity Tests, Molecular Structure, Nitroso Compounds/*chemical synthesis/chemistry, Pyridines/*chemical synthesis/chemistry/pharmacology, Stereoisomerism, Structure-Activity Relationship | Pathogenicity | |
22304453 | Synthesis and in vitro antimicrobial activity of new 4-phenyl-5-methyl-4H-1,2,4-triazole-3-thione derivatives. | Popiolek L, Kosikowska U, Dobosz M, Malm A | J Enzyme Inhib Med Chem | 10.3109/14756366.2011.653352 | 2012 | Anti-Infective Agents/*chemical synthesis/chemistry/*pharmacology, Chemistry Techniques, Synthetic, Cyclization, Drug Evaluation, Preclinical/methods, Gram-Positive Bacteria/drug effects, Microbial Sensitivity Tests, Micrococcus luteus/drug effects, Staphylococcus aureus/drug effects, Thiadiazoles/chemistry, Triazoles/chemistry | Pathogenicity | |
23603688 | Site-directed mutations in the lanthipeptide mutacin 1140. | Chen S, Wilson-Stanford S, Cromwell W, Hillman JD, Guerrero A, Allen CA, Sorg JA, Smith L | Appl Environ Microbiol | 10.1128/AEM.00704-13 | 2013 | Bacteriocins/*genetics/isolation & purification/pharmacology, Biotechnology/*methods, Clostridioides difficile/drug effects, Genes, Transgenic, Suicide/genetics, Genetic Vectors/genetics, Micrococcus luteus/drug effects, Molecular Structure, Mutagenesis, Site-Directed/*methods, Peptides/*genetics/isolation & purification/pharmacology, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Staphylococcus aureus/drug effects, Streptococcus/drug effects, Streptococcus mutans/*genetics/metabolism | Pathogenicity | Enzymology |
23710121 | Synthesis and antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives. | Popiolek L, Kosikowska U, Mazur L, Dobosz M, Malm A | Med Chem Res | 10.1007/s00044-012-0302-9 | 2012 | |||
24374431 | Taguchi's experimental design for optimizing the production of novel thermostable polypeptide antibiotic from Geobacillus pallidus SAT4. | Muhammad SA, Ahmed S, Ismail T, Hameed A | Pak J Pharm Sci | 2014 | Anti-Bacterial Agents/*biosynthesis, Geobacillus/classification/*metabolism, Peptides/*metabolism, *Research Design | Metabolism | Biotechnology | |
25229869 | Bactericidal activity of nukacin ISK-1: an alternative mode of action. | Roy U, Islam MR, Nagao J, Iida H, Mahin AA, Li M, Zendo T, Nakayama J, Sonomoto K | Biosci Biotechnol Biochem | 10.1080/09168451.2014.918485 | 2014 | Anti-Bacterial Agents/isolation & purification/*pharmacology, Bacteria/drug effects, Bacteriocins/isolation & purification/*pharmacology | Enzymology | Phylogeny |
28699251 | Antituberculotic activity of actinobacteria isolated from the rare habitats. | Hussain A, Rather MA, Shah AM, Bhat ZS, Shah A, Ahmad Z, Parvaiz Hassan Q | Lett Appl Microbiol | 10.1111/lam.12773 | 2017 | Actinobacteria/classification/genetics/*isolation & purification/*metabolism, Antitubercular Agents/chemistry/*metabolism/pharmacology, Bacillus subtilis/drug effects, Ecosystem, Escherichia coli/drug effects, Gas Chromatography-Mass Spectrometry, India, Klebsiella pneumoniae/drug effects, Microbial Sensitivity Tests, Phylogeny, Pseudomonas aeruginosa/drug effects, Soil Microbiology | Phylogeny | Pathogenicity |
30532629 | Identification and characterization of a novel antimicrobial peptide compound produced by Bacillus megaterium strain isolated from oral microflora. | Al-Thubiani ASA, Maher YA, Fathi A, Abourehab MAS, Alarjah M, Khan MSA, Al-Ghamdi SB | Saudi Pharm J | 10.1016/j.jsps.2018.05.019 | 2018 | Phylogeny | ||
32888099 | Intracellular biosynthesis of PbS quantum dots using Pseudomonas aeruginosa ATCC 27853: evaluation of antibacterial effects and DNA cleavage activities. | Ocal N, Ceylan A, Duman F | World J Microbiol Biotechnol | 10.1007/s11274-020-02917-z | 2020 | Anti-Bacterial Agents/*biosynthesis/chemistry/*pharmacology, Antifungal Agents/chemistry/pharmacology, Bacteria/drug effects, DNA Cleavage/*drug effects, Escherichia coli/drug effects, Fungi/drug effects, Lead/*chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Transmission, Nanoparticles, Nanostructures/chemistry, Particle Size, Pseudomonas aeruginosa/*metabolism, Quantum Dots/chemistry/*metabolism, Spectrophotometry, Ultraviolet, Sulfides/*chemistry, X-Ray Diffraction | Pathogenicity | Metabolism |
33172144 | Rheological and Antimicrobial Properties of Chitosan and Quinoa Protein Filmogenic Suspensions with Thyme and Rosemary Essential Oils. | Escamilla-Garcia M, Rios-Romo RA, Melgarejo-Mancilla A, Diaz-Ramirez M, Hernandez-Hernandez HM, Amaro-Reyes A, Pierro PD, Regalado-Gonzalez C | Foods | 10.3390/foods9111616 | 2020 | |||
35265106 | Biosynthesis and Characterization of Silver Nanoparticles Produced by Phormidium ambiguum and Desertifilum tharense Cyanobacteria. | Hanna AL, Hamouda HM, Goda HA, Sadik MW, Moghanm FS, Ghoneim AM, Alenezi MA, Alnomasy SF, Alam P, Elsayed TR | Bioinorg Chem Appl | 10.1155/2022/9072508 | 2022 | |||
36013417 | Inhibitory Effect of Bacillus licheniformis Strains Isolated from Canine Oral Cavity. | Surin Hudakova N, Kacirova J, Sondorova M, Selianova S, Mucha R, Madar M | Life (Basel) | 10.3390/life12081238 | 2022 | Phylogeny | ||
36431827 | Antibacterial Properties of Crotoxin from Crotalus durissus terrificus-Insight into the Mechanism of Action. | Nemecz D, Golinska P | Molecules | 10.3390/molecules27227726 | 2022 | Animals, Humans, *Crotoxin/pharmacology, Crotalus/metabolism, Phospholipases A2/pharmacology, Anti-Bacterial Agents/pharmacology, Escherichia coli/metabolism | Pathogenicity | Metabolism |
Reference
@id | authors | catalogue | doi/url | title |
---|---|---|---|---|
656 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 1790) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-1790 | |
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
41170 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/17044 | ||
47536 | Curators of the CCUG | Culture Collection University of Gothenburg (CCUG) (CCUG 21988) | https://www.ccug.se/strain?id=21988 | |
68382 | Automatically annotated from API zym | |||
77111 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID13723.1 | StrainInfo: A central database for resolving microbial strain identifiers | |
120705 | Curators of the CIP | Collection of Institut Pasteur (CIP 53.160) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2053.160 |